The study showed a protective effect of the osteoprotegerin (OPG) CGA haplotype on the risk of cardiovascular disease in patients who were anti-cyclic citrullinated peptide (anti-CCP) negative. This evidence concerns the gene TNFRSF11B and cardiovascular disorder.